Resources
February 4, 2021
On World Cancer Day, we pause to recognize the toll cancer takes on patients and ways generics and biosimilars are easing the financial burden.
December 22, 2020
A biosimilar is a medicine that is highly similar to a brand biologic medicine, providing the same treatment benefits.
November 16, 2020
Join the Biosimilars Council along with 17 other IGBA associations in building awareness of the benefits of biosimilars.
November 10, 2020
Today, the U.S. Supreme Court will hear arguments on the constitutionality of the Affordable Care Act (ACA). Although the case relates to the individual insurance mandate contained in the law, it could affect more than just this question.
October 26, 2020
The Biologics Price Competition and Innovation Act of 2010 (BPCIA) provides a framework for biosimilars approval, adoption and access in the U.S.
October 12, 2020
Patent abuse and anti-competitive activities limit the ability of biosimilars to reach the market in a timely manner and ultimately hurt patients.
